Schedules of Controlled Substances: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I of the Controlled Substances Act

Document 2024-07689 is a Final Rule published by the Department of Justice in the Federal Register on April 11, 2024, with an effective date of April 12, 2024. The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of butonitazene, flunitazene, and metodesnitazene, as identified in this order. The schedule I status of these three substances currently is in effect through April 12, 2024. This temporary order will extend the temporary scheduling of these three substances for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first. View the original at https://www.federalregister.gov/documents/2024/04/11/2024-07689/schedules-of-controlled-substances-extension-of-temporary-placement-of-butonitazene-flunitazene-and.

No. Document 2024-07689 is not classified as economically significant under Executive Order 12866. Economically significant rules require OIRA review and are estimated to have impacts of $100 million or more per year.